Beneficial microorganisms are widely used in agriculture for control of plant pathogens, but a lack of efficacy and safety information has limited the exploitation of multiple promising biopesticides. We applied phylogeny-led genome mining, metabolite analyses and biological control assays to define the efficacy of Burkholderia ambifaria, a naturally beneficial bacterium with proven biocontrol properties but potential pathogenic risk. A panel of 64 B. ambifaria strains demonstrated significant antimicrobial activity against priority plant pathogens. Genome sequencing, specialized metabolite biosynthetic gene cluster mining and metabolite analysis revealed an armoury of known and unknown pathways within B. ambifaria. The biosynthetic gene cluster responsible for the production of the metabolite cepacin was identified and directly shown to mediate protection of germinating crops against Pythium damping-off disease. B. ambifaria maintained biopesticidal protection and overall fitness in the soil after deletion of its third replicon, a non-essential plasmid associated with virulence in Burkholderia cepacia complex bacteria. Removal of the third replicon reduced B. ambifaria persistence in a murine respiratory infection model. Here, we show that by using interdisciplinary phylogenomic, metabolomic and functional approaches, the mode of action of natural biological control agents related to pathogens can be systematically established to facilitate their future exploitation.
N umerous bacterial and fungal species have been recognized for their biological control abilities and plant growthenhancing properties. Man-made pesticides conventionally used in agriculture are under increasing scrutiny regarding their bioaccumulation and toxicity, which includes their fatal effect on pollinator species. Concern over chemical pesticides has reinvigorated research into biological control agents and their secreted bioactive compounds as viable natural alternatives for agriculture. One feature common to most biopesticidal species is their ability to secrete antimicrobial compounds into the environment and inhibit pathogenic microorganisms from causing crop disease. Bacteria within the genus Burkholderia are particularly diverse in their specialized metabolism and have a documented ability to produce a range of potent antibacterial, antinematodal and antifungal compounds 1, 2 . They have demonstrated excellent promise as biological control agents, with multiple strains used commercially as biopesticides until 1999. In common with other biological control genera, such as Bacillus, Pseudomonas and Stenotrophomonas, certain Burkholderia species may also cause human, animal and plant infections. Thus, in 1999, the US Environmental Protection Agency placed a moratorium on new registrations of Burkholderia biopesticides unless such agents were defined as safe in terms of their risk of opportunistic infection 2 .
Multiple species within the Burkholderia cepacia complex group were characterized or used as biological control agents 2 . They are highly active in their specialized metabolism, for example, producing antifungal compounds including pyrrolnitrin, occidiofungin, cepafungin and burkholdines; antibacterial bactobolins and enacyloxin IIa; and broader-spectrum agents such as the cepacins 3, 4 . Outside of the B. cepacia complex, other Burkholderia species also produce a range of antagonistic compounds. The bactobolins are also produced by Burkholderia thailandensis and Burkholderia pseudomallei and exhibit potent activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus 5 . Burkholderia gladioli also produces multiple antimicrobials, including the antimycobacterial macrolide gladiolin 6 , its isomer lagriene 7 , the cytotoxic azapteridine toxoflavin 8 and the polyyne caryoynencin 9 . There is no consensus on the distribution or co-occurrence of antimicrobial specialized metabolite-encoding gene clusters in biopesticidal Burkholderia ambifaria, nor a holistic understanding of strain bioactivity and antimicrobial compound efficacy against priority bacterial 10, 11 , fungal and oomycetal plant pathogens 2 . Biopesticidal activities have been descriptively characterized for individual producer strains against a panel of target organisms, or multiple producer strains against relatively few target organisms 2 . Previous studies have analysed the overall antagonistic properties of B. ambifaria, but none has examined the role of specific antimicrobial compounds in mediating biocontrol in natural soil microcosm models.
To establish a biotechnological platform for biopesticidal use of B. ambifaria that considers its efficacy and safety, we systematically defined the genomic basis and functional efficacy of antimicrobial metabolites in 64 strains, including 8 previously characterized biocontrol strains (Supplementary Table 1 ). The strain collection examined included 58 environmental isolates recovered from multiple sources (soil, the maize, pea and grass rhizosphere, and leaves) and 6 strains isolated from the sputum of people with cystic fibrosis. Collectively, it also represented strains recovered from various geographical origins (the United States, Australia and Italy; Supplementary Table 1 ). The B. ambifaria core and accessory genome was revealed, and gene cluster network analyses were combined with antimicrobial activity assays to rationally understand the biopesticidal activity against crop pathogens. The role of individual antimicrobial metabolites in mediating crop protection was investigated using biosynthetic pathway mutants in non-sterile soil biocontrol models. As curing of the B. cepacia complex third genomic replicon (c3) is possible in these multireplicon bacteria 12 , a B. ambifaria c3 mutant was constructed and shown to have reduced virulence in a murine respiratory infection model, yet retained its plant-protective properties. This work provides a foundation for developing targeted biological control agents and effective biocontrol products for reducing agricultural crop losses from bacterial, fungal and oomycete pathogens.
Results
B. ambifaria genomics and in silico definition of specialized metabolite biosynthetic gene clusters. To understand the genome-encoded potential of B. ambifaria as a biopesticide, phylogenomic and pan-genomic analyses were applied (see Methods, Supplementary Fig. 1 , Supplementary Table 2 and Supplementary Notes). The three replicon genomic structure was present in 63 of the B. ambifaria strains analysed, whereas strain BCC1105 naturally lacked the third replicon. Contigs were scaffolded to one of three reference genomes to assemble complete genomes. The assembled genome sizes varied across the 64 strains, from 6.13 Mb (BCC1105) to 8.03 Mb (BCC1248), with a mean of 7.34 Mb (Supplementary  Table 2 ). Assembled replicons c1, c2 and c3 possessed a mean of 3.47 Mb, 2.74 Mb and 1.15 Mb, respectively. Replicon c3 possessed the greatest variation in sequence capacity, whereas replicons c2 and c1 displayed greater consistency in size (Supplementary Table 2 ). A large B. ambifaria pan-genome was identified (22,376 distinct genes), of which 3,784 genes comprised the core genome. The pan-genome represented a collection of genes approximately 3.4-fold greater than the mean B. ambifaria genome (6,546 genes). A large proportion of the accessory genome, 78.1% (14,582 genes), was shared by less than 15% of the B. ambifaria strains. Exclusion of the strain BCC1105, which lacked the third replicon, from the core genome analysis resulted in the B. ambifaria core genome increasing from 3,784 to 4,166 genes. Three major clades were identified in the B. ambifaria 3,784 core gene phylogeny (Fig. 1a ), and this established the evolutionary framework onto which the In a, the phylogenetic tree was constructed based on 3,784 core genes identified and aligned using the software Roary. The root was determined using a secondary tree containing an outgroup species, B. vietnamiensis G4 ( Supplementary Fig. 10 ). Six clades were defined in the phylogeny; however, the strains BCC1066 and MEX-5 branched outside these clades. Strains subject to further LC-MS analysis are in bold; strains with historical biocontrol usage are indicated with an asterisk. RAxML was used to construct the maximum-likelihood phylogeny using the generalized time reversible model with a GAMMA substitution (100 bootstraps). Nodes with bootstrap values of <70% are indicated with black circles. The evolutionary distance scale bar represents the number of base substitutions per site. In b, the presence of the eight characterized antifungal and antibacterial gene clusters-pyrrolnitrin, burkholdine, AFC-BC11, hydroxyquinolines, cepacin A, bactobolins, phenazine and enacyloxin IIa-in the 64 B. ambifaria strains are ordered by phylogenetic position. The matrix was generated using Phandango 50 . In c, the antimicrobial activity of 62 B. ambifaria strains were defined by measuring the diameter of the zones of inhibition (mm); n = 2 overlays of each B. ambifaria strain against each susceptibility organism. The heatmap shows the mean zone of inhibition. The strains MEX-5 and IOP40-10 were not available for the antimicrobial production assay. D. solani, Dickeya solani; P. carotovorum, Pectobacterium carotovorum; P. savastanoi, Pseudomonas savastanoi; P. syringae, Pseudomonas syringae; X. campestris, Xanthomonas campestris.
antimicrobial properties of each strain were overlaid using in silico and bioactivity approaches. In silico analyses of the 64 B. ambifaria genomes (see Methods, Supplementary Table 3 and Supplementary Notes) detected 1,272 specialized metabolite biosynthetic gene clusters (BGCs), that were dereplicated into 38 distinct BGCs after Kmer-matching and gene topology comparisons ( Fig. 2 and Supplementary Table 3 ). Network analysis was used to graphically summarize multiple attributes of the B. ambifaria BGCs, including their biosynthetic diversity, strain distribution and core or accessory nature within the species (Fig. 2 ). Of the 38 distinct BGCs, 13 were previously characterized and 7 were known to encode compounds with antimicrobial activity (Supplementary Table 4 ). Pyrrolnitrin 13 was the only BGC for an antimicrobial metabolite found in all 64 B. ambifaria strains, whereas the BGC for the anti-Gram-negative metabolite enacyloxin IIa 3 was the least common known antimicrobial BGC ( Fig. 2 ). Pyrrolnitrin and phenazine BGCs were encoded on replicon c2, and the remaining antagonistic compounds were encoded by BGCs on replicon c3. No known antimicrobial BGCs were identified on replicon c1. Barring a few exceptions, multiple antimicrobial-encoding BGCs were associated with distinct clades within the B. ambifaria core gene phylogeny ( Fig. 1 ). Six of the seven clade 1b strains encoded the pathway responsible for enacyloxin IIa biosynthesis 3 . The more widely distributed burkholdine 14 BGC was absent from all members of clade 2 and strain BCC1105, but all other strains possessed this antifungal biosynthetic locus. Bactobolin 5 BGCs were concentrated in clade 1 and were less frequently encountered in clades 2 and 3. Two strains, BCC1105 and BCC1224, only encoded the core antifungal metabolite pyrrolnitrin and lacked any additional antimicrobial BGCs (Fig. 1b ). No single strain encoded all seven previously known antimicrobial BGCs; however, approximately 59% of strains encoded four or more BGCs reflecting the known antimicrobial properties of B. ambifaria (Fig. 1b) .
The silent nature of certain antimicrobial BGCs that are not expressed in standard laboratory cultures, including those in Burkholderia, is well established 3, 4 . Thus, we correlated in vitro metabolite production with BGC distribution. Ten B. ambifaria strains representing the seven characterized biocontrol strains and three additional strains from the broader species phylogeny ( Fig. 1a) were screened for metabolite production on agar growth media BSM-G (basal salts medium supplemented with 4 g l −1 glycerol) 3, 15 . Six known antimicrobial metabolites were detected by liquid chromatography-mass spectrometry (LC-MS) ( Supplementary Figs. 2 and 3 ), five of which could be directly correlated to the presence of predicted BGCs (Table 1) . Under these screening conditions, the majority of BGCs (22 of 25) were biosynthetically active and produced the corresponding metabolite; individual strains containing pyrrolnitrin, burkholdine and hydroxyquinoline BGCs were exceptions to this trend ( Table 1) . A sixth known metabolite, cepacin A 16 , was also detected in B. ambifaria J82 (BCC0191) by LC-MS analyses (see Methods) and subsequently correlated to a BGC (not recognized by anti-SMASH v3) 17 identified by searching for quorum sensingregulated gene clusters (see below).
Mapping direct antimicrobial activity against plant and animal pathogens.
Having established the presence of BGCs (Figs. 1b and 2) and corresponding metabolites ( Table 1) , antagonism activity of the 64 B. ambifaria strains against priority plant 10 and human pathogens (Supplementary Table 5 ) was evaluated as described 3 . The in vitro bioactivity was aligned against the core gene phylogeny to map antagonism across B. ambifaria as a species (Fig. 1c ). A total of six strains lacked observable antimicrobial activity ( Fig. 1c ). Clade 1a, 1b and 1c strains exhibited substantial bioactivity against Gram-negative pathogens, whereas only two strains outside these clades exhibited similar activity ( Fig. 1c ). Clade 1b strains exhibited additional strong antagonistic activity towards Betaproteobacteria, Burkholderia multivorans, and Alphaproteobacteria, Rhizobium radiobacter ( Fig. 1c ), an activity that was not observed in other anti-Gram-negative B. ambifaria strains. The extended antimicrobial antagonism of clade 1b B. ambifaria correlated to the presence of the hybrid cis-acyltransferase (AT) PKS/trans-AT PKS nonribosomal peptide synthase (NRPS) BGC for enacyloxin IIa (Fig. 1b) ; all screened Gram-negative pathogens were susceptible to purified enacyloxin IIa with minimum inhibitory concentrations ranging from 3.2 to 50 µg ml −1 (Supplementary Table 6 ). The additional anti-Gram-negative activity correlated to the presence of the hybrid NRPS-PKS-encoding BGC for bactobolin ( Fig. 1b ). Antifungal (against Candida albicans, Fusarium solani and Alternaria alternata) and anti-Gram-positive (against S. aureus, Enterococcus faecalis and Bacillus subtilis) activity was more widespread than anti-Gram-negative activity in B. ambifaria, with 82% 
BGCs in specific strains where the corresponding metabolite was not detected. b Detected before identification of its BGC.
and 69% of tested strains (62 of 64) exhibiting these activities, respectively ( Fig. 1 ). Clade 2 B. ambifaria strains exhibited the least antimicrobial activity (five of nine lacking any in vitro observable activity) despite containing BGCs for pyrrolnitrin, hydroxyquinolines and cepacin ( Fig. 1b) .
A search for quorum sensing-regulated BGCs reveals the biosynthetic locus for the potent anti-oomycetal cepacin. Multiple specialized metabolite BGCs are quorum sensing controlled 3, 4 , and manipulation of this regulatory system has also been harnessed for Burkholderia metabolite discovery 18 . A search of luxR homologues within the B. ambifaria genomes was performed (see Supplementary Notes), and downstream of an uncharacterized LuxRI system (encoded by 22 of 64 strains) ( Fig. 3 ) was a conspicuous BGC encoding fatty acid desaturases, a β-ketoacyl synthase and an acyl carrier protein ( Fig. 4a ). Insertional mutagenesis of a fatty acyl-AMP ligase-encoding gene, ccnJ, within this BCG was carried out in six B. ambifaria strain backgrounds (BCC0191, BCC1252, BCC1241, BCC0477, BCC1259 and BCC1218; Fig. 1 ). The resulting mutants lacked anti-Gram-positive activity and the weak anti-Gram-negative activity, and showed considerably diminished growth inhibition of the oomycete Pythium ultimum ( Fig. 4b and Supplementary  Fig. 4 ). High-resolution mass spectrometry of metabolite extracts from strain BCC0191 identified ions with m/z = 271.0964, corresponding to a molecular formula of C 16 H 14 O 4 consistent with cepacin A, a historically described Burkholderia polyyne 16 of undefined biosynthetic origin. Direct comparison with extracts from the originally reported cepacin A and cepacin B producer strain, 'B. cepacia' ATCC 39356 (ref. 16 )(taxonomically reclassified as a Burkholderia diffusa strain), confirmed that B. ambifaria BCC0191 produces cepacin A ( Supplementary Fig. 5 ). Cepacin A was absent in the B. ambifaria BCC0191::ccnJ cepacin insertional mutant ( Fig. 4c ), confirming that the uncharacterized LuxRI-associated BGC was responsible for the biosynthesis of this known Burkholderia metabolite. The cepacin A BGC is located on the second replicon of 22 B. ambifaria strains, with 100% and 56% presence in clade 3 and clade 2 strains, respectively ( Fig. 1b) .
Cepacin A is a key mediator of B. ambifaria biocontrol of P. ultimum damping-off disease. B. ambifaria has been observed to inhibit P. ultimum, and application to prevent crop damping-off diseases was a key trait in its historical biopesticide use 2 . However, the metabolites and/or BGCs that drive Burkholderia crop protection against Pythium-mediated damping-off have not been defined in a relevant biopesticide model, such as bacterial seed coating and planting in pathogen-infested soil 2 . The cepacin producer B. ambifaria BCC0191 exhibited strong biopesticidal activity when introduced as a Pisum sativum (pea) seed coat to a P. ultimum biocontrol model in non-sterile soil ( Fig. 5a ). Disruption of the cepacin BGC and application of the BCC0191 cepacin mutant as a seed coat reduced pea plant survival rates by more than 60%, depending on the B. ambifaria seed coat inoculum level (10 5 , 10 6 and 10 7 colony-forming units (c.f.u.) per seed; Fig. 5a ). No biological control was observed when 10 5 c.f.u. per seed of BCC0191 cepacin mutant was applied (<10% survival), compared to >50% protection mediated by the wild type (WT) at this level ( Fig. 5a ). A unique feature of the B. cepacia complex multi-replicon genome is that the third replicon is not essential and c3 deletion mutants lose virulence and antifungal phenotypes 12 . The cepacin BGC is located on the second c2 replicon of B. ambifaria, and its biosynthesis was maintained when a third replicon deletion mutant, BCC0191Δc3, was constructed. Despite the loss of >1 Mb DNA, the BCC0191Δc3 derivative remained competitive and biopesticidal in the Pythium-infested soil microbial community, protecting peas from damping-off at a rate marginally below that of the WT (Fig. 5b ; the difference was not significant for a given inoculation size). The phenotypes of B. ambifaria BCC0191, its cepacin-deficient derivative (::ccnJ), c3-knockout mutant (Δc3) and combined cepacin-c3 mutation (::ccnJΔc3) were tested further to understand the wider effect of these mutations on strain fitness (see Supplementary Notes). Antimicrobial activity against Gram-positive bacteria and Pythium was lost in the cepacin-deficient mutant ( Supplementary  Fig. 6 ). The BCC0191 c3 mutant lost antifungal activity but had a twofold increase in cepacin production, enhancing its anti-Grampositive antagonism ( Supplementary Fig. 6 ). Rhizocompetence was 28 similar for the BCC0191 WT and the BCC0191::ccnJ strains, but the third replicon deletion mutant colonized the pea rhizosphere at a significantly lower rate of 8.5 × 10 6 c.f.u. per g of root (P = 0.027; Supplementary Table 7) . A lack of understanding of safety and human pathogenicity were key reasons that the US Environmental Protection Agency placed a moratorium on B. cepacia complex biopesticides 2 . As the BCC0191Δc3 mutant had retained its biopesticidal ability ( Fig. 5b ), yet loss of this replicon is associated with reduced virulence in multiple infection models 12 , we assessed the pathogenicity of B. ambifaria BCC0191 and its c3 deletion mutant. In the Galleria mellonella wax moth larvae model 12 , the deletion of the third replicon did not attenuate the virulence ( Supplementary Fig. 7a ), showing that genes encoding significant insecticidal pathogenicity were not encoded on c3 in B. ambifaria strain BCC0191. By contrast, using a murine respiratory infection model relevant to chronic cystic fibrosis lung infections 19, 20 , the persistence of B. ambifaria BCC0191 was low and loss of the third replicon in the BCC0191Δc3 mutant further reduced persistence in the lung ( Supplementary Fig. 7b,c) . At an infective dose of 2 × 10 6 bacteria, the BCC0191 WT strain persisted in the nasopharynx for the duration of the 5-d experiment but was cleared from the lungs of 4 out of 6 mice by day 5. By contrast, the c3 mutant was rapidly cleared from both the nasopharynx and the lungs of mice ( Supplementary Fig. 8 ). Low numbers of the parental BCC0191 strain (<50 colonies) were detected in the lungs of mice after 5 d of infection, but BCC0191Δc3 was cleared within 48 h. B. ambifaria (WT or c3 mutant) was not detected within the spleens of infected mice and no visible disease signs were observed throughout. Genotyping by PCR demonstrated that the low number of colonies recovered from the mouse infection model were either the administered B. ambifaria BCC0191 or BCC0191Δc3 strains ( Supplementary Fig. 8 ).
Discussion
Harnessing the potential of naturally biopesticidal bacteria is an important consideration if we are to keep pace with agricultural intensification and global food security. With increasing regulatory and environmental scrutiny of pesticides, the properties of natural agents will also have to be systematically defined before widespread use. Our in-depth genomic analysis of the intra-species diversity of B. ambifaria as a biopesticide and direct linkage of its specific metabolite, cepacin A, to the antagonism of Pythium and prevention of crop damping-off disease, sets a precedent on the mode of action of Burkholderia biopesticides. We have developed a holistic understanding of biopesticidal B. ambifaria, determining their pan-genomic content, extensive library of antimicrobial BGCs, efficacy in targeting key plant pathogens with specific antimicrobial metabolites and defining the population biology of historically applied B. ambifaria biopesticides (see Supplementary Discussion) . We have shown that biological control of damping-off disease in a relevant soil model is critically mediated by cepacin A, encoded on the second replicon of B. ambifaria. As effective biological control of Pythium also occurs in the absence of the third replicon, which has been characterized as a Burkholderia virulence plasmid 12 , we have highlighted this as an attenuation strategy for developing potentially safe biopesticide strains that retain biotechnological efficacy.
Discovery of cepacin BGC.
Mining and phylogenetically clustering the LuxR protein sequences from 64 B. ambifaria genomes revealed multiple solo and luxI-associated luxR genes, and these were linked with both known and uncharacterized specialized metabolite BGCs. In addition to the B. ambifaria encoded enacyloxin 3 and bactobolin 5 BGCs, LuxR regulation of other specialized metabolite BGCs has been further described within and outside the genus. B. thailandensis synthesizes the quorum sensing-regulated cytotoxic compound malleilactone 21 , and pyocyanin production in Pseudomonas aeruginosa is controlled by a hierarchical quorum sensing network 22 . This approach was initially intended to understand the role of quorum sensing regulation in B. ambifaria biopesticidal specialized metabolism, but serendipitously led to the identification of the cepacin A BGC.
Cepacins A and B were initially described as metabolites of B. cepacia, formally Pseudomonas cepacia 16, 23 , with the original producer strain now classified as B. diffusa 24 . Both polyyne metabolites displayed strong anti-staphylococci activity, whereas cepacin A showed weak anti-Gram-negative activity 16 . Cluster K, a gene cluster with 76.9% homologous nucleotide similarity spanning 12.9 kb (in addition to 8.4 kb of non-homologous regions) to the B. ambifaria cepacin A BGC was identified in Collimonas fungivorans Ter331 using nucleotide BLAST ( Supplementary Fig. 9 ). The C. fungivorans cluster K has been linked to the biosynthesis of the antifungal polyyne collimomycin 25 whose BGC organization ( Supplementary Fig. 9 ) and chemical formula (C 16 H 18 O 4 ) resemble cepacin A (C 16 H 14 O 4 ). Recent characterization of this C. fungivorans strain showed that it produces a range of polyynes, collectively designated the collimonins 26 , with collimonin A showing the most structural similarity to cepacin A. Several key differences in gene content were identified between the cepacin and collimonin BGCs in the regions flanking the core biosynthetic genes ( Supplementary  Fig. 9 ). C. fungivorans cluster K contains genes encoding four additional hypothetical proteins, a major facilitator superfamily transporter and fatty acid desaturase; whereas the B. ambifaria cepacin BGC encoded one extra hypothetical protein. An unusual feature of the cepacin and collimonin BGC variants is the substitution of the associated regulatory genes that comprise a quorum sensingassociated luxRI in Burkholderia and a lysR regulator in Collimonas ( Supplementary Fig. 9 ). Similar proteins to those identified in the cepacin BGC are listed in Supplementary Table 8 .
Cepacin A is a major component of B. ambifaria biological control. We have demonstrated the importance of cepacin A in the context of biological control for pathogens of the major crop family Fabaceae (P. sativum). Disruption of the cepacin BGC in B. ambifaria T3SS (64) Unknown (2) Adjacent, but divergent, solo luxR genes T3SS (64)
Enacyloxin IIa
Bactobolins (17) Cluster of interest (22) QS system bafRI/cepRI (61) Butyrolactone (27) QS system cepR2I2 (63) Unknown (3) Unknown (12) IOP40-10 QS system (luxRI) (1) Ectoine (4) Lantipeptide (10) 0.4 significantly reduced plant survival beyond germination and emergence compared to the WT ( Fig. 5a ; P < 0.05). The contribution of specific metabolites to biocontrol has been studied extensively in Pseudomonas 27 relative to other characterized biocontrol genera. The antifungal properties of pyrrolnitrin and 2,4-diacetylphloroglucinol have been evidenced as important metabolites in the biological control of several fungal pathogens, on a diversity of crops, in a range of Pseudomonas species and strain backgrounds 27 . Other studies have highlighted the in vitro antimicrobial activity and the presence of the corresponding specialized metabolite BGCs or protective effects in field trials in Bacillus 28 and Streptomyces 29 , but fail to define the impact of distinct metabolites in a biocontrol system. This study establishes the role of cepacin A as the major bioactive component of the B. ambifaria armoury in the biocontrol of damping-off disease by P. ultimum in a relevant non-sterile soil model. The reduced protection against P. ultimum of the cepacin A-deficient mutant compared to the WT B. ambifaria also indirectly confirms the expression of the cepacin A BGC in planta (Fig. 5b ).
There has been considerable discussion on whether Burkholderia species known to cause opportunistic infections can be safely exploited for environmental benefit 30 . Multiple species in the recently defined Paraburkholderia genus have not been associated with infection, are generally environmental and mediate plant-beneficial interactions 30 . Transfer of biopesticidal properties, such as the B. ambifaria cepacin BGC to Paraburkholderia species, is a potential route to future safe usage. Attenuation of pathogenicity in biopesticidal strains is an alternative means to facilitate their biotechnological exploitation. Third replicon deletion in B. ambifaria BCC0191 led to the loss of persistence in the murine lung infection model ( Supplementary Fig. 7b,c) , and hence provides an unmarked means of attenuating pathogenicity but preserving biopesticidal potential in this strain (see Supplementary Discussion and Fig. 5 ). In addition, the BCC0191Δc3 mutant also showed a reduced root colonization after 14 d compared to the WT strain (see Supplementary  Discussion and Supplementary Table 7 ), suggesting that it has less potential for bioaccumulation, which is another desirable trait for a biopesticide. Whether c3 deletion is sufficient to render B. ambifaria as a species completely avirulent remains to be fully determined. B. ambifaria is rarely found in cystic fibrosis lung infections, with a survey of US patients from 1997 to 2007 implicating that it collectively, with several other B. cepacia complex species, causes <3% of all Burkholderia cases 31 . A 2017 survey of Burkholderia infections in 361 UK patients with cystic fibrosis did not find B. ambifaria at all 32 . These epidemiological data combined with the low murine respiratory persistence of B. ambifaria ( Supplementary Fig. 7b ,c) compared to virulent pathogens, such as P. aeruginosa 19, 20 , indicate that B. ambifaria has low pathogenicity. From this start point, attenuation of virulence using unmarked c3 deletion as performed herein, combined with further essential gene mutation strategies as used to construct live bacterial vaccines, could also provide a route towards the development of safe B. ambifaria biopesticides.
Conclusion
Biological control agents have been applied to crops with success in the past, but no in-depth genomic or analytical chemistry analyses have been conducted on individual species to assess their biocontrol Supplementary Fig. 3 ).
potential. This study demonstrated the benefits of using genome mining and in vitro antimicrobial screening to define BGCs that contribute to biocontrol and enable their use in the rational design of future bacterial biopesticides. The potential of cepacin-producing B. ambifaria in protecting economically relevant crop species from attack by oomycete pathogens has been demonstrated. It is clear that B. ambifaria has accumulated multiple plant-protective BGCs that underpin its historical exploitation as a biopesticide 2 . With an urgent need to sustain crop protection and agricultural production, yet reduce the use of environmentally persistent synthetic pesticides, systematically repurposing natural biological control agents, such as B. ambifaria, for biotechnology is a timely alternative solution.
Methods
Genome sequencing and replicon assembly. Genomes used in this study were either sequenced as part of this study or downloaded from public databases. For 60 B. ambifaria genomes ( Supplementary Table 1 ), 125-nucleotide and 150-nucleotide paired-end reads were generated using an Illumina HiSeq 2000 and HiSeq X Ten, respectively. Illumina adaptors were trimmed, read quality was assessed and contigs were assembled as described in the Supplementary Notes. Genomic contigs were rearranged and scaffolded into replicons by mapping the contigs against three reference genomes using CONTIGuator v2.7.4 (ref. 33 ). The option to fill gaps using strings of 'N' was disabled. Reference genomes were B. ambifaria AMMD (SAMN02598309) and B. ambifaria MC40-6 (SAMN02598385), both obtained from the European Nucleotide Archive; the third reference, B. ambifaria BCC0203, was generated using Pacific Biosciences single-molecule real-time sequencing. The replicons were manually assessed for any scaffolding errors and corrected when necessary. Completed replicons (c1, c2 and c3) were recircularized based on the genes dnaA, parA and parB, respectively, using the software Circlator v1.2.1 (ref. 34 ). The species validity of the B. ambifaria data set was defined by calculating the average nucleotide identity shared between all available B. ambifaria genomes using PyANI v0.2.1 (ref. 35 ). Two sequenced strains from this study (BCC1630 and BCC1638) and one publicly available strain (RZ2MS16) were excluded from the data set, using a 95% average nucleotide identity species threshold 36 . The remaining 64 B. ambifaria strains along with mutant derivatives used in this study are listed in Supplementary Table 1 .
Genome mining and specialized metabolite BGC network analysis. All bioinformatics analyses were performed using the Cloud Infrastructure for Microbial Bioinformatics (CLIMB) computing resource 37 . Scaffolded replicons and non-scaffolded contigs were annotated using Prokka v1.12-beta 38 . The bioinformatics tool antiSMASH v.3.0.5 (ref. 17 ) detected specialized metabolite BGCs in both scaffolded and non-scaffolded contig sequences. Known pathways that were not detected by antiSMASH were identified with nucleotide-nucleotide BLAST v2.6.0+ 39 mediated by B. ambifaria cepacin. a, Pea germination (14 d) in P. ultimum-infested soil observed for groups of 10 seeds coated with 10 7 , 10 6 and 10 5 c.f.u., respectively, of BCC0191 WT and BCC0191::ccnJ (left). The overall percentage survival of germinating peas (P. sativum) treated with the WT and BCC0191::ccnJ B. ambifaria strains is shown on the right. Survival was assessed as plants that had stems of >30 mm in height after 14 d. Plant survival was significantly different at every inoculum level between BCC0191 WT and BCC0191::ccnJ strains, as indicated by two-sided t-test or Welch's two-sided t-test (*P < 0.05; **P < 0.01); significant difference (left to right) P = 0.002, P = 0.03, P = 0.002 with 95% confidence interval. n = 10 seeds per condition (seed coat) and dosage (c.f.u. per seed), repeated in triplicate. The centre bar represents the mean, and the error bars represent the standard error. b, Pea germination (14 d) in P. ultimum-infested soil observed for groups of 10 seeds coated with 10 7 , 10 6 and 10 5 c.f.u., respectively, of BCC0191 WT and BCC0191Δc3 strains (left). The overall percentage survival of germinating peas treated with BCC0191 WT and BCC0191Δc3 is shown on the right. No significant difference (left to right: P = 0.22, P = 0.22, P = 0.16) was observed, as determined by two-sided t-test with 95% confidence interval, in plant survival between BCC0191 WT and BCC0191Δc3 at all inoculum levels. n = 10 seeds per condition (seed coat) and dosage (c.f.u. per seed), repeated in triplicate. The centre bar represents the mean, and the error bars represent the standard error.
Kmer-matching software Mash v1.1.1 (ref. 40 ), reporting a maximum P value and maximum distance of 1 and 0.05, respectively. The resulting distance matrix was visualized with Cytoscape v3.4.0 (ref. 41 ), applying the Jaccard index, P value and Mash distance (the estimated mutation rate between sequences) as edge attributes. Duplicated edges between nodes and self-loops were removed from the network analysis. The resulting cluster network was further refined by comparing the gene topologies of pathway representatives from network clusters of the same specialized metabolite class, and splitting or merging network clusters where necessary.
Genomic analysis and phylogenomics. The core and accessory genome of the collective 64 B. ambifaria strains was calculated using Roary v3.7.0 (ref. 42 ) using a 95% minimum percentage identity for blastp and a core gene threshold of 99% occurrence across the 64 strains. The core gene alignment generated by Roary was used to construct an approximate maximum-likelihood core gene phylogeny with double-precision FastTree v2.1.9 (ref. 43 ). The root position was determined by including the outgroup species Burkholderia vietnamiensis G4 (PRJNA10696) ( Supplementary Fig. 10 ). Once the root branch point was defined, a second tree was constructed using RAxML v8.2.11 (ref. 44 ) with the general time reversible substitution and a GAMMA model of rate heterogeneity supported by 100 bootstraps.
Culture conditions and antimicrobial activity screens. All B. ambifaria strains were grown in TSB at 37 °C and aerated overnight, unless stated otherwise. The 64 B. ambifaria strains were screened for the production of antimicrobials with antagonistic activity against 14 plant, animal and human pathogens, and other reference species (Supplementary Table 5 ). A standard overlay assay was used to screen for antimicrobial activity, as previously described 3 , with the amendment of using 400 μl overnight culture of the susceptibility-testing organism per 100 ml half-strength iso-sensitest agar. A strain was considered antagonistic if the zone of inhibition was >10 mm in diameter. Antagonism assays with A. alternata and F. solani involved the resuspension of mycelia in 1 ml PBS from 9-day-old cultures grown in 50-mm Petri dishes on potato dextrose agar; 320 μl mycelial resuspension was used per 100 ml half-strength iso-sensitest agar before pouring as an overlay. Square Petri dishes (10 × 10 cm) containing BSM-G were used to screen six isolates concomitantly, and a replicator was used to transfer the bacterial culture onto the agar surface from 96-well plates. B. ambifaria strains were grown on BSM-G for 3 d at 30 °C. Each 96-well plate stored six strains tested for antimicrobial activity, with 200 μl overnight culture grown in TSB broth (Oxoid) per used well and DMSO at a final concentration of 8% for −80 °C storage. Following chloroform-killing, approximately 25 ml antimicrobial susceptibility test organism-seeded half-strength iso-sensitest agar was poured over each 10 × 10 cm square Petri dish. The plates were incubated at the optimum temperatures of each susceptibility test organism (Supplementary Table 5 ). The heatmap of pathogen antagonism was created in statistics software R v3.2.3 via RStudio v0.99.484.
Confirmation of the Burkholderia cepacin A BGC-metabolite link.
Insertional mutagenesis was used to disrupt the expression of the cepacin A pathway. Primers were designed to amplify a 649-bp region of the fatty acyl-AMP ligase-encoding gene ( Supplementary Table 9 ), yielding a final product of 707 bp. The product was amplified using the Taq PCR Master Mix Kit (Qiagen) and ligated into the suicide vector pGp-omega-Tp 45 following restriction with XbaI and EcoRI (NEB). The resulting construct was transformed into competent Escherichia coli SY327 via heat shock (maintained by trimethoprim selection; 50 μg ml −1 ) and subsequently introduced into B. ambifaria via triparental mating with E. coli HB101 carrying the helper plasmid pRK2013 (kanamycin selection, 50 μg ml −1 ). The transconjugants were selected using 150 μg ml −1 trimethoprim and 600 U ml −1 polymyxin. The presence and correct location of the insertional vector were confirmed by PCR. Comparative high-performance liquid chromatography (HPLC) and antimicrobial activity screens between the WT strain and the insertional mutant confirmed that production of cepacin had been abolished.
Construction and phenotypic analysis of a B. ambifaria BCC0191Δc3 mutant.
The B. ambifaria BCC0191Δc3 mutant was constructed following the methods outlined in Agnoli et al. 12 . This involved using the pMiniC3 vector, a 12.6-kb plasmid constructed from the origin of replication of the B. cenocepacia H111 third replicon and containing its repA, parB and parA genes, and trimethoprim resistance and sucrose counter selection cassettes 12 . In brief, the pMiniC3 vector was mated into the BCC0191 WT strain to displace the native c3 replicon via a triparental mating involving the donor E. coli MC1061 pMiniC3, recipient B. ambifaria BCC0191 and E. coli HB101 carrying the helper plasmid pRK2013. B. ambifaria BCC0191 pMinic3 clones were subsequently cured of pMinic3 by sucrose counterselection. B. ambifaria BCC0191Δc3 clones were screened for the absence of both replicon c3 and plasmid pMinic3 by PCR using the DreamTaq Green PCR Master Mix (2×) (Thermo Scientific) (Supplementary Table 9 ). The virulence of B. ambifaria BCC0191 and its Δc3 mutant was evaluated in G. mellonella wax moth larvae 12 and murine chronic lung 19, 20 infection models as described below.
Detection of LuxR homologues as specialized metabolite regulators. LuxRencoding gene homologues were identified by replicating the systematic in silico approach previously described 46 . In brief, a hidden Markov model was built to identify potential LuxR-encoding genes; these candidates were annotated for encoded protein domains. Candidate genes were considered LuxR encoding if all four conserved LuxR protein domains were detected. The extracted amino acid sequences were aligned using MAFFT v7.305b 47 and a phylogenetic tree generated using FastTree v2.1.9 (ref. 43 ). The regulatory function of the luxR gene was inferred either from the literature or from genes with putative functions starting within 5 kb upstream and downstream of the luxR gene.
Culture conditions, extraction protocol and high-resolution mass spectrometry. All B. ambifaria strains were grown at 30 °C on BSM-G. The original cepacin producer, strain ATCC 395396, was obtained from the Belgium Coordinated Collection of Microorganisms where it is deposited as B. diffusa strain LMG 24093. Single plates were extracted by addition of 4 ml acetonitrile for 2 h, followed by centrifugation to remove debris. Crude extracts were directly analysed by UHPLC-ESI-Q-TOF-MS. UHPLC-ESI-Q-TOF-MS analyses were performed using a Dionex UltiMate 3000 UHPLC connected to a Zorbax Eclipse Plus C-18 column (100 × 2.1 mm, 1.8 μm) coupled to a Bruker MaXis II mass spectrometer. Mobile phases consisted of water (A) and acetonitrile (B), each supplemented with 0.1% formic acid. A gradient of 5% B to 100% B over 30 min was used at a flow rate of 0.2 ml min −1 . The mass spectrometer was operated in positive-ion mode with a scan range of 50-3,000 m/z. Source conditions were: end-plate offset at −500 V, capillary at −4,500 V, nebulizer gas (N 2 ) at 1.6 bar, dry gas (N 2 ) at 8 l min −1 and dry temperature at 180 °C. Ion transfer conditions were: ion funnel radio frequency (RF) at 200 Vpp, multiple RF at 200 Vpp, quadrupole low mass at 55 m/z, collision energy at 5.0 eV, collision RF at 600 Vpp, ion cooler RF at 50-350 Vpp, transfer time at 121 μs and pre-pulse storage time at 1 μs. Calibration was performed with 1 mM sodium formate through a loop injection of 20 μl at the start of each run.
Biocontrol of P. ultimum using a P. sativum model. The infestation of soil with P. ultimum Trow var. ultimum (MUCL 16164) was developed from the methodology proposed in Toda et al. 48 . Plugs of P. ultimum were grown at approximately 22 °C on PDA for 3 d. Infested soil was produced by mixing the surface mycelia from the PDA agar plates into a 5/1 compost/sand mixture (one 90-mm PDA Petri dish per 120 g soil) and incubating the soil at approximately 22 °C for 3 d. Potting mix was composed of 1% (w/w) Pythium-infested soil in unsterilized non-infested soil or 100% unsterilized non-infested soil for a noninfested control. Unsterilized P. sativum seeds (Early Onward cultivar) were coated with B. ambifaria before planting. B. ambifaria coating suspension was produced as follows: an overnight (approximately 18 h) TSB culture of B. ambifaria was washed in sterile 1× volume PBS and resuspended in sterile 0.5× volume PBS. The suspension was adjusted to 10 × 0.5 absorbance units at 600 nm (approximately 10 9 c.f.u. per ml), and either applied at the neat concentration or diluted to achieve the desired inoculum levels (10 8 and 10 7 c.f.u. per ml). Control P. sativum seeds lacking the B. ambifaria coating were dipped in PBS. P. sativum plants were grown at 22 °C with a 16-h light/8-h dark photoperiod (70% relative humidity) for 14 d and watered as required. Groups of ten seeds per inoculum and seed coat organism were assayed per experiment, and the experiment was performed in triplicate. Significant differences between BCC0191 WT and mutant derivatives were assessed using two-tailed t-test or Welch's two-tailed t-test. Two-tailed ttest assumptions were normally distributed data (Shapiro-Wilk test) and equal variances (Bartlett test); Welch's two-tailed t-test did not assume equal variances.
Metabolite extraction and HPLC analysis.
To confirm the absence of cepacin A in the BGC mutants constructed for the different B. ambifaria strain backgrounds (BCC0191, BCC1252, BCC1241, BCC0477, BCC1259 and BCC1218; Supplementary Fig. 3 ), each strain was grown on BSM-G agar for 3 d at 22 o C, the bacterial growth was removed and an equal amount of agar (a 2-cm disc) was extracted with 0.5 ml ethyl acetate for 2 h at room temperature. This was fractionated on an acetonitrile gradient (5-95%) using a Waters AutoPurification HPLC System fitted with a reverse-phase analytical column (Waters XSelect CSH C18, 4.6 × 100 mm, 5 μm). Metabolites eluted from the column were detected by a photodiode array, and the peak corresponding to cepacin A was identified by its retention time; LC-MS also confirmed the presence of the polyyne in this fraction.
In vivo killing assay using Galleria wax moth larvae. G. mellonella wax moth larvae were sourced from BioSystems Technology Ltd TruLarv. Bacterial cultures of the BCC0191 WT and BCC0191Δc3 strains were grown overnight (approximately 18 h) in TSB broth at 37 °C, washed and resuspended in 1× volume PBS before being adjusted to approximately 1 × 10 6 c.f.u. per ml. Larvae were injected in the hindmost proleg on the right side of the abdomen. Each larva was injected with 10 µl aliquots of B. ambifaria BCC0191 WT and BCC0191Δc3 bacterial suspensions with a 25 G × 1″ needle (BD Microlance 3) using a 1705TLL, 50 µl syringe (Hamilton). PBS injections were included as controls. Each condition included ten larvae, and the experiment was performed in triplicate over 3 d. The larvae were incubated at 37 °C for 72 h, and their survival status was monitored at 18, 24, 42, 48, 66 and 72 h post-inoculation. Larvae were recorded as dead when they failed to respond to physical agitation. The total viable count of the bacterial suspensions was calculated during the first and third replicate via drop-count.
The mean average c.f.u. per ml of BCC0191 WT and BCC0191Δc3 suspensions were 1.5 × 10 6 c.f.u. per ml and 1.0 × 10 6 c.f.u. per ml, respectively.
Murine chronic lung infection model.
A murine respiratory infection model as used for modelling P. aeruginosa pathogenicity was applied to B. ambifaria essentially as described 19, 20 . All experiments were carried out at the University of Liverpool with approval from the UK Home Office and University ethics committee. Randomization of mice to cages (experimental groups) was performed by animal unit staff with no role in study design as described 19 . An initial dosing experiment demonstrated good tolerance of an infectious dose of 10 6 B. ambifaria, equivalent to that used for P. aeruginosa in previous studies 19, 20 . Sample size was calculated to give 95% power at α = 0.05 to detect a >4-fold difference in lung c.f.u. between BCC0191 and BCC0191Δc3, assuming a mean c.f.u. of 100 in the BCC0191 lung and a standard deviation of 50% of the mean (as determined in preliminary experiments). Groups of 6 mice (female BALB/c, 6-8-weeks old; Charles River) were infected intranasally under anaesthesia (O 2 /isolfuorane), achieving an actual dose of 2 × 10 6 B. ambifaria BCC0191 or its third chromosome replicon mutant BCC0191Δc3. Symptoms of disease were monitored and mice were culled at 24 h, 48 h and 5 d post-infection. Researchers were not blinded to the experimental groupings. The nasopharyngeal tissue, lungs and spleens were removed, homogenized in 3 ml PBS, serial dilutions were prepared and plated onto B. cepacia selective agar (Oxoid) for enumeration of surviving B. ambifaria. No animals were excluded from the analysis. Colonies from the tissue of mice carrying infection were confirmed to be strain B. ambifaria BCC0191 by random amplified polymorphic DNA typing (see Supplementary Fig. 8 ).
Rhizocompetence of B. ambifaria BCC0191 WT and derivatives.
The rhizocompetence of B. ambifaria BCC0191 and its derived mutants were evaluated essentially as described 49 . Liquid cultures of BCC0191, BCC0191::ccnJ and BCC01911Δc3 were grown in TSB broth overnight at 37 °C (50 µg ml −1 trimethoprim for BCC0191::ccnJ), then washed and resuspended in 1× volume PBS and adjusted to 1 × 10 9 c.f.u. per ml. P. sativum (pea) seeds were coated in the bacterial suspensions and planted in a potting mix composed of 5/1 multi-purpose compost to sand. The seeds were germinated and grown at 22 °C with a 16-h light/8-h dark photoperiod (70% RH) for 14 d and watered as required. After 14 d, the plants were removed and excess soil was shaken from the root systems. The first to second centimetre of root was excised, macerated in 1 ml PBS and serially diluted. Dilutions of the root suspension were plated onto B. cepacia selective agar (Oxoid) and incubated at 37 °C for 24 h to calculate total viable counts. Three plants were used per strain derivative and three un-inoculated seeds were included as a control. Any growth from the control plants was subject to random amplified polymorphic DNA typing PCR profiling to distinguish the bacteria from B. ambifaria. Non-B. ambifaria growth on the control plates was discounted from the total viable counts. Total viable counts were standardised to 1 g fresh weight of root.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Code availability
The publicly available software and codes used for genome sequence determination, phylogenomics, mass spectrometry and general statistical analysis are described in the appropriate Methods sections.
Data availability
Sequence data that support the genomic findings of this study have been deposited in the European Nucleotide Archive with the accession/bioproject codes listed in Supplementary Table 1 . The data that support the antimicrobial production, P. sativum and G. mellonella survival and murine infection model findings of this study are available from the corresponding authors on request. Bacterial strains and constructs will be made available on written request to the corresponding authors and after signing a Material Transfer Agreement. We are restricted in redistributing certain bacterial strains, such as those from recognized culture collections, but such requests will be redirected to the appropriate source. 
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Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists may be useful.
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Data collection
The Illumina HiSeq software suite (HCS 2.2.68) was used for collection of genome sequence data. The Bruker maXis II software was used for collection of mass spectrometry data and Waters Mass Lynx software used for HPLC analysis. Microsoft office suite 2016 was used to collect text and numerical data for the manuscript. For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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